On Monday 9 August, health authorities in Guinea, a country in West Africa, confirmed a case of Marburg virus disease located in the southern Gueckedou prefecture.
This is the first time that the virus has ever been identified in West Africa.
What has happened in Ghana?
Ghana has confirmed its first two cases of the Marburg virus, with officials stating that both patients died recently in hospital in the southern Ashanti region.
Samples from both cases came back positive for the virus earlier this month, and have since been verified by a lab in Senegal.
Health officials say that 98 people have been placed under quarantine as suspected contact cases - this includes relatives, medics and mortuary workers who came into contact with the two patients in question.
Dr Matshidiso Moeti, the World Health Organisation’s (WHO) Africa director, praised Ghana for its swift response to the virus.
Dr Moeti said: “This is good because without immediate and decisive action, Marburg can easily get out of hand.”
Speaking to BBC Focus on Africa radio, Dr Patrick Kumah-Aboagye, the head of Ghana’s health service, added: “There’s a whole multi-disciplinary team in the field trying to ensure that we are able to unearth the real source of this.”
What is the Marburg virus?
WHO explains that the Marburg virus is a “highly virulent disease that causes haemorrhagic fever, with a fatality ratio of up to 88 per cent”.
The virus is in the same family of viruses that causes the Ebola virus, and it was two large outbreaks that occurred simultaneously in Marburg and Frankfurt in Germany, and in Belgrade, Serbia, in 1967 that led to the initial recognition of the virus.
Since then, WHO says, outbreaks and sporadic cases have been reported in “Angola, Democratic Republic of the Congo, Kenya, South Africa (in a person with recent travel history to Zimbabwe) and Uganda”.
Additionally, in 2008, two separate cases of the virus were reported in travellers who had visited a case inhabited by Rousettus bat colonies in Uganda.
In 2005, the virus killed more than 200 people in Angola, making it the deadliest outbreak on record.
“Human infection with Marburg virus disease initially results from prolonged exposure to mines or caves inhabited by Rousettus bat colonies,” the WHO says.
“Once an individual is infected with the virus, Marburg can spread through human to human transmission via direct contact (through broken skin or mucous membranes) with the blood, secretions, organs or other bodily fluids of infected people, and with surfaces and materials (e.g bedding, clothing) contaminated with thee fluids.”
What are the symptoms of the virus?
Symptoms caused by Marburg virus begin very suddenly, with a high fever, severe headache and severe malaise.
Muscle aches and pains are also a common feature, and on the third day, severe watery diarrhoea, abdominal pain and cramping, nausea and vomiting is all to be expected.
WHO says: “The appearance of patients at this phase has been described as showing “ghost-like” drawn features, deep-set eyes, expressionless faces and extreme lethargy.”
Between two and seven days after the onset of symptoms, a non-itchy rash has also been reported.
Within seven days, many patients develop “severe haemorrhagic manifestations”, and fatal cases usually have bleeding from multiple areas.
“Fresh blood in vomitus and faeces is often accompanied by bleeding from the nose, gums and vagina,” WHO explains.
In fatal cases of the virus, death usually occurs between eight and nine days after the onset of symptoms, usually preceded by severe blood loss and shock.
The incubation period for Marburg virus varied between two and 21 days.
Can the virus be treated?
WHO says that supportive care, like rehydration with oral or intravenous fluids, and the treatment of specific symptoms improves the survival of patients with the virus.
However, “there is as yet no proven treatment available for Marburg disease”.
Currently being evaluated are treatments including the likes of immune therapies, drug therapies and blood products.
What happened in Guinea last year?
Less than two months after Guinea declared an end to the Ebola outbreak that surfaced in early 2021, the Marburg virus was detected in samples taken from a now-deceased patient.
The samples, which were tested by a field laboratory in Gueckedou as well as Guinea’s national haemorrhagic fever laboratory, came back positive for the virus. The result was further confirmed by analysis conducted by the Institut Pasteur in Senegal.
The patient had sought treatment at a local clinic in the Koundou area, where a medical team had been sent to investigate his worsening symptoms.
“The potential for the Marburg virus to spread far and wide means we need to stop it in its tracks.
“We are working with the health authorities to implement a swift response that builds on Guinea’s past experience and expertise in managing Ebola, which is transmitted in a similar way.”